2013-02-25 14:00:24 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to PT Pyridam Farma Tbk and produced a Rating Update Report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal – SADIF Investment Analytics, announces a new Rating Update Report covering PT Pyridam Farma Tbk (PYFA). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential PT Pyridam Farma Tbk investor.
Report Summary: PT Pyridam Farma Tbk is an average quality company with a positive outlook. PT Pyridam Farma Tbk has weak business growth and is run by passable management. The trend in PT Pyridam Farma Tbk fair value exchange rate against its closest rated-competitor, PT Indofarma (Persero) Tbk, has been depreciating over the past 2 weeks. When compared to its closest competitor, PT Pyridam Farma Tbk shows less undervaluation and is equally likely to underperform the market.
The 3-page report breaks
down the Total StockMark into its three components – business, management and price, performing an in-depth analysis of PT Pyridam Farma Tbk for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, West Services, Advisen, Alacra-Datadownlink, Factiva, INTERNET SECURITIES and LEXIS/NEXIS or directly from SADIF-Investment Analytics at:
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering sixteen different markets and over 12,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.